A Political Reset, or to Play to His Base: Researcher Available to Discuss Trump’s First Address to Congress
Georgia State University
The Institute for Biomedical Sciences (IBMS) at Georgia State University is offering two new graduate degree programs designed to prepare students for careers in the biomedical sciences that will enhance human health and bring scientific discoveries to market.
Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn’t influence disease outcomes in white patients, according to a new study.
Noma LeMoine, chief educational officer of LeMoine and Associates Educational Consulting, will deliver the 28th annual Benjamin E. Mays Lecture on Feb. 21 at 6:30 p.m. in the Georgia State University Student Center East Ballroom (55 Gilmer St. SE, Atlanta).
Dr. Anne Murphy, a neuroscientist of Georgia State University, has received a five-year, $1.8 million grant from the National Institutes of Health (NIH), to investigate pain management therapies for people aged 65 or older.
Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.
The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections.
An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study.